Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs Lam Research Corporation (LRCX) Price & Performance

Amphastar Pharmaceuticals IncTrade
Lam Research CorporationTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs Lam Research Corporation — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Lam Research Corporation trades at $324 (market cap $389.67B). The key difference: Lam Research Corporation is far larger — about 448.6× Amphastar Pharmaceuticals Inc's market cap, and Lam Research Corporation pays a 0.33% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMPHLRCX
Market Cap
$868.62M$389.67B
Sector
HealthTechnology
52-Week High
$30.81$433.33
52-Week Low
$16.87$97.03
Enterprise Value
$1.27B$387.83B
Dividend Yield
0.33%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About Lam Research Corporation

Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.

Read more on LRCX